Down syndrome

Lore & Background

Down syndrome is caused by the presence of all or part of a third copy of chromosome 21. The parents of the affected individual are usually genetically normal. The incidence increases with the age of the mother, from less than 0.1% for 20-year-old mothers to 3% for those of age 45. It is believed to occur by chance, with no known behavioral activity or environmental factor that changes the probability. Three genetic forms exist: trisomy 21 (most common), translocation Down syndrome, and mosaic Down syndrome (1–2% of cases).

Reader's Guide

There is no cure, but education and proper care improve quality of life. Some children are educated in typical school classes; about 20% of adults in the United States do some paid work, often requiring a sheltered environment. Life expectancy is around 50 to 60 years in the developed world with proper health care. Regular screening for health issues such as congenital heart disease, epilepsy, leukemia, and thyroid diseases is recommended. Since the introduction of prenatal screening, Down syndrome pregnancies are often aborted, with rates varying from 50 to 85% depending on maternal age, gestational age, and maternal race/ethnicity.

Did You Know?

• Down syndrome is caused by the presence of all or part of a third copy of chromosome 21.
• The incidence increases with maternal age, from less than 0.1% at age 20 to 3% at age 45.
• About 20% of adults with Down syndrome in the United States do some paid work.
• Life expectancy is around 50 to 60 years in the developed world with proper health care.

The Genetic Blueprint

Down syndrome stems from a single chromosomal anomaly: the presence of an entire or partial third copy of chromosome 21. In nearly every case, both parents carry perfectly normal genetic material, and the event is understood to be a matter of chance rather than the result of any behavior, lifestyle choice, or environmental exposure. The likelihood does climb with maternal age, rising from under one in a thousand for a twenty-year-old mother to roughly three percent for a woman at forty-five, yet no specific activity has ever been shown to shift those odds.

Three distinct genetic configurations have been catalogued. The predominant form, trisomy 21, delivers an entire extra chromosome into every cell at the moment the egg and sperm fuse. Translocation Down syndrome instead tethers surplus chromosome-21 material onto another chromosome. The rarest variant, mosaic Down syndrome, accounts for only one to two percent of cases; here the extra genetic material is introduced during early embryonic development, so only a subset of the body's cells carries it. This partial involvement typically yields milder cognitive effects, with IQ scores running ten to thirty points above those seen in the full-trisomy form.

The Body and the Mind

The physical signature of Down syndrome is recognizable yet varied. A small chin, epicanthic folds, a flat nasal bridge, low muscle tone, and a protruding tongue—often the result of weak facial musculature that myofunctional exercises can help correct—form the most visible markers. Joint hypermobility, a single transverse palm crease, short fingers, and extra space between the big and second toes add to the profile. Characteristic airway features push obstructive sleep apnea to roughly half of all affected individuals. Stature is typically shorter, with adult men averaging about 154 centimetres and women around 142, and obesity risk grows with age partly due to higher hypothyroidism incidence.

Cognitively, most adults display mental abilities comparable to those of an eight- or nine-year-old, yet their emotional and social awareness is notably strong. Developmental milestones arrive later: independent crawling usually lands between eight and twenty-two months, and unassisted walking between one and four years. Language comprehension tends to outpace expressive speech, and a stutter or rapid, irregular speech pattern affects ten to forty-five percent of individuals. Seizure risk spans five to ten percent in childhood and can reach fifty percent in adulthood, while roughly fifteen percent who survive past forty develop Alzheimer's disease.

Living, Learning, and Working

No medical cure exists for Down syndrome, but structured education and consistent healthcare have been shown to meaningfully improve quality of life. Some children thrive in mainstream classrooms alongside their peers, while others benefit from more specialized instructional settings. A portion of individuals go on to graduate from high school, and a smaller number pursue post-secondary education. In adulthood, roughly twenty percent of those in the United States engage in some form of paid employment, though many of these roles take place within sheltered work environments. Because of ongoing cognitive and practical challenges, caregivers frequently step in to manage financial decisions and legal matters on the individual's behalf.

Health surveillance is a lifelong necessity. Congenital heart disease, epilepsy, leukemia, and thyroid disorders all occur at elevated rates, and regular screening throughout life is recommended. In the developed world, life expectancy with proper medical care now falls in the range of fifty to sixty years. The condition can be detected before birth through prenatal screening and confirmatory diagnostic testing, or after delivery via direct physical observation and genetic analysis.

Naming, Numbers, and a Shifting Global Picture

Down syndrome is the most common chromosomal abnormality in humans, affecting approximately one in every one thousand live births worldwide and one in seven hundred in the United States. By 2015, an estimated 5.4 million people were living with the condition globally. Mortality has declined substantially: 27,000 deaths were recorded in 2015, down from 43,000 in 1990, a reduction that reflects advances in pediatric cardiology, early intervention, and broader access to healthcare.

The syndrome bears the name of British physician John Langdon Down, who devoted much of his medical practice to studying and advocating for the condition. However, earlier observations had been made by French psychiatrist Jean-Étienne Dominique Esquirol in 1838 and French physician Édouard Séguin in 1844, who described several of the characteristic features before the chromosomal basis was understood. The actual genetic mechanism—the extra chromosome 21—was not identified until 1959, a full century after those first clinical descriptions.